A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer
In a population-based group of women, consecutively diagnosed, with premenopausal breast cancer there was a significant correlation between tumour size and plasma prolactin (r=0.30;P